Author:
Fletcher Peter,De Santis Marta,Ippoliti Simona,Orecchia Luca,Charlesworth Philip,Barrett Tristan,Kastner Christof
Reference39 articles.
1. Cancer incidence and mortality projections in the UK until 2035;Smittenaar;Br J Cancer,2016
2. Optimal biopsy approach for detection of clinically significant prostate cancer;Ippoliti;Br J Radiol,2022
3. National Institute for Health and Care Excellence. Prostate cancer: diagnosis and management. NICE guideline 131. London, UK: NICE; 2019. www.nice.org.uk/guidance/ng131.
4. Mottet N, Cornford P, van den Bergh RCN, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Arnhem, The Netherlands: European Association of Urology; 2022. https://uroweb.org/guidelines/prostate-cancer.
5. Orecchia L, Nardi A, Fletcher P, et al. Natural history of patients with prostate MRI Likert 1–3 and development of RosCaP: a multivariate risk score for clinically significant cancer. Clin Genitourin Cancer. In press. https://doi.org/10.1016/j.clgc.2022.07.011.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献